By Ts. Ng Kuak Ping, FIFST — Lead Formulator & Founder, W.S.T Apotheca · Technical Director, Bionutricia Holding Sdn Bhd (since 2006) · Professional Food Technologist (MBOT) · Registered Food Analyst (Malaysian Food Analysts Council, MOH) · Patent owner, MY188945A Published 28 May 2026 · Last reviewed 28 May 2026 · Author profile → · LinkedIn →
At a glance
Bergamot (Citrus bergamia Risso et Poiteau) is a small citrus fruit grown almost exclusively along the Calabrian coast of southern Italy. Its standardized polyphenolic extract — rich in flavonoids such as naringin, neoeriocitrin and neohesperidin — has, in randomized human trials, lowered total cholesterol by roughly 9% and LDL cholesterol by roughly 12% over four months, with a small favorable shift in HDL.
Daily dose used in trials: 150–500 mg of standardized flavonoids per day. Time to measurable effect: 4–12 weeks. Strongest 2024 evidence: a four-month placebo-controlled RCT published in Foods (November 2024) found −8.8% total cholesterol, −11.5% LDL, +5.5% HDL trend, and −2.0% oxidized-LDL in 64 hypercholesterolemic adults at 150 mg/day standardized flavonoids (Mollace et al., 2024 — PMC11641072). Safety: very well tolerated in published trials; main caution is drug interaction with statins via shared LDL-receptor and CYP3A4 pathways.
What bergamot is, and why the chemistry matters
The bergamot fruit grows almost nowhere else on Earth in commercially meaningful quantity. The peel is the source of bergamot essential oil used in Earl Grey tea and perfumery — but the juice and whole-fruit polyphenolic extract are what concern us here. Bergamot’s flavonoid profile is unusual: it contains brutieridin and melitidin, two molecules with a statin-like 3-hydroxy-3-methylglutaryl side chain that appear to inhibit HMG-CoA reductase — the same enzyme statins target — but at a much gentler scale, and through additional mechanisms including LDL-receptor up-regulation and PCSK9 modulation (Mollace et al., 2024; Toth et al., 2023 — bergamot phytocomplex RCT, PMC10507770).
That mechanism, plus a low side-effect rate, is why bergamot has become the most clinically interesting natural cholesterol-management ingredient of the last decade.
The 2024 trial in plain English
Sixty-four adults with high cholesterol were randomized to either 150 mg/day of standardized Citrus bergamia flavonoids or placebo, for four months. They were measured at baseline, one month, two months and four months.
Headline outcomes at four months (Mollace et al., 2024; NutraIngredients summary, March 2025):
| Marker | Change | Statistically significant? |
|---|---|---|
| Total cholesterol | −8.8% | Yes |
| LDL-C | −11.5% | Yes |
| HDL-C | +5.5% | Trending toward significance |
| Oxidized LDL | −2.0% | Yes |
| PON1 (paraoxonase-1) | +6.5% | Yes |
| Secondary endpoints (liver enzymes, kidney function, blood pressure) | No change | Good tolerability |
Two things matter about that result. First, the LDL drop is the kind of magnitude you used to see only with low-dose statins — at a flavonoid dose that fits comfortably in a single capsule. Second, the rise in PON1 (an HDL-bound enzyme that protects LDL from oxidation) and the drop in oxidized LDL point to a qualitative improvement in lipid biology, not just lower numbers.
A separate 2023 three-arm placebo-controlled trial of a standardized bergamot phytocomplex found broadly similar results, with additional improvement in flow-mediated dilation — a measure of vascular function (Mollace et al., 2023 — PMC10507770).
How bergamot compares to berberine
This is the most-asked question on the topic, so here is the honest comparison.
Berberine has the larger evidence base for glucose control. A 2025 systematic review and meta-analysis of randomized placebo-controlled trials concluded that berberine significantly reduces triglycerides, fasting plasma glucose, waist circumference, total cholesterol, LDL-C and BMI; effects on HDL-C and blood pressure were not significant (Anjuwon-Foster et al., 2025 — Frontiers in Pharmacology; PubMed 40740996).
Bergamot has narrower but cleaner evidence for lipid control specifically, with a notably better tolerability profile — berberine commonly causes GI side effects (nausea, constipation, mild abdominal discomfort) whereas bergamot trials report essentially placebo-level adverse events.
The pragmatic answer: if your concern is fasting glucose or insulin sensitivity, berberine has the stronger evidence; if your concern is LDL and oxidized-LDL specifically, bergamot is at least as well-supported and easier to tolerate. The two are often combined in modern metabolic formulations (W.S.T Apotheca’s Metatheca leads with Citrus bergamia extract and stacks supporting actives across both mechanisms).
Who should not take bergamot
The clinical trials have been remarkably clean on safety, but a few cautions matter:
- People on statins. Bergamot’s HMG-CoA reductase activity is additive with statins, and grapefruit-class citrus polyphenols can inhibit CYP3A4 — the enzyme that clears most statins. Combining without medical supervision can raise statin blood levels and muscle-toxicity risk. Discuss with your prescribing doctor.
- Pregnancy and breastfeeding. No human safety data; avoid.
- People on anticoagulants. Theoretical interaction; conservative approach is to clear with a healthcare professional.
- Anyone preparing for surgery. Stop two weeks before, like most botanical supplements.
What “standardized extract” means and why you should care
Not all bergamot extracts are equivalent. The trials above used standardized polyphenolic fractions with assayed concentrations of naringin, neoeriocitrin, neohesperidin, brutieridin and melitidin — the molecules that actually do the work. A juice powder or unspecified “bergamot extract” on a label can vary 10-fold in active content.
When you buy a bergamot supplement, look for:
- A flavonoid assay disclosed on the label (e.g. “standardized to ≥38% total flavonoids” or “150 mg standardized polyphenolic fraction”).
- Country of origin: Calabria, Italy, is the authentic source. Other origins can be authentic but require verification.
- A daily dose in the 150–500 mg/day range of the standardized fraction — not the raw extract.
- HPLC assay availability on request.
W.S.T Apotheca Metatheca uses a 250 mg per capsule, 500 mg per day, Calabrian-sourced Citrus bergamia extract with assay-on-COA disclosure. See the full Metatheca ingredient page →.
How bergamot fits into a broader metabolic strategy
Bergamot is a useful tool, not a substitute for the basics. Across the metabolic-syndrome literature, the most robust interventions remain weight management, fiber-rich diet, resistance training, sleep, and where indicated, prescribed medication. Botanicals and standardized extracts can meaningfully nudge lipid biology — bergamot is one of the better-supported examples — but they work best layered on top of those foundations, not in place of them (Mayo Clinic — Metabolic syndrome).
A 2025 narrative review on bergamot in cardiometabolic aging frames it well: bergamot’s value is as part of a multi-mechanism approach — anti-inflammatory, lipid-modulating, antioxidant, and gently insulin-sensitizing — rather than as a single-bullet intervention (Springer — Nutrire 2025).
Frequently asked questions
Is bergamot the same as Earl Grey tea? Earl Grey is black tea perfumed with bergamot peel essential oil, used in tiny amounts for flavor. The clinical effect on cholesterol comes from a concentrated polyphenolic extract of the whole fruit, not from drinking Earl Grey. You would have to drink roughly 100 cups a day to approach the dose used in trials, and you would not get the right flavonoid profile.
Can I take bergamot with a statin? Only under medical supervision. Bergamot’s HMG-CoA reductase activity is additive with statins, and citrus polyphenols can inhibit CYP3A4 — the enzyme that clears many statins. The combination can raise statin levels and increase the risk of muscle-related side effects. Talk to your prescribing doctor before stacking.
How long until I see a change in my cholesterol numbers? In the published trials, measurable LDL changes appeared at the first follow-up at four weeks and continued to deepen through four months. Plan for a 12-week minimum trial before drawing conclusions, and re-test lipids at week 12 or 16.
Does bergamot help with weight loss? Indirectly, at most. Bergamot’s documented effects are on lipid metabolism and oxidative stress markers, not on body weight. Some trials show modest waist-circumference improvements when bergamot is combined with diet and other actives, but bergamot is not a weight-loss supplement.
Is 150 mg or 500 mg the right daily dose? Both are within the trial range. The November 2024 RCT achieved its ~12% LDL reduction at 150 mg/day standardized flavonoids over four months. Higher doses (up to 500–1,000 mg/day of extract) have been used in other trials with proportionally greater effect; the cost–benefit is usually a 250–500 mg/day extract dose providing 150–300 mg of standardized fraction.
Is the bergamot in Metatheca authentic Calabrian Citrus bergamia? Yes. Metatheca uses a Calabrian-source standardized extract with the flavonoid assay disclosed on the certificate of analysis. We require species, origin and assay documentation on every incoming lot.
References
- Mollace V, Rosano GMC, et al. Citrus bergamia Extract, a Natural Approach for Cholesterol and Lipid Metabolism Management: A Randomized, Double-Blind Placebo-Controlled Clinical Trial. Foods 2024;13(23):3883. PMC11641072 · MDPI
- Anjuwon-Foster BR, et al. Efficacy and safety of berberine on the components of metabolic syndrome: a systematic review and meta-analysis of randomized placebo-controlled trials. Frontiers in Pharmacology 2025;16:1572197. PubMed 40740996 · Full text
- Mollace V, et al. Metabolic and vascular effect of a new standardized bergamot phytocomplex: a three-arm, placebo-controlled, double-blind clinical trial. Archives of Medical Science 2023. PMC10507770
- Janda E, Mollace V, et al. The Effect of Natural Antioxidants in the Development of Metabolic Syndrome: Focus on Bergamot Polyphenolic Fraction. Nutrients 2020;12(5):1504. PMC7284500
- Carresi C, et al. Bergamot in cardiometabolic aging. Nutrire 2025;50:5. Springer
- Mayo Clinic. Metabolic syndrome. mayoclinic.org
This article is for educational purposes and is not medical advice. Consult a qualified healthcare professional before starting any supplement, especially if you take prescription medication, are pregnant or breastfeeding, or have a diagnosed medical condition.